Last Price
0.507
Today's Change
-0.012 (2.30%)
Day's Change
0.481 - 0.52
Trading Volume
35,647
Profile
ENVB
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Joseph Edward Tucker Ph.D. Dr. Joseph Edward Tucker Ph.D.
Full Time Employees: 7 7
IPO Date: 2015-05-04 2015-05-04
CIK: 0000890821 0000890821
ISIN: US29405E2081 US29405E2081
CUSIP: 29405E208 29405E208
Beta: 0.50 0.50
Last Dividend: 0.00 0.00
Dcf Diff: -0.55 -0.55
Dcf: 1.06 1.06
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Ultra-rich Families Set to Control US$9.5 Tril by 2030, Says Deloitte
2
CEO Morning Brief
3
CEO Morning Brief
4
CEO Morning Brief
US Trade Deficit Widens to US$78.8 Bil, Largest in Two Years
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
